Google
×
Anagrelide is used to decrease the risk of blood clots in patients who have thrombocythemia (too many platelets in the blood). It works to decrease the production of platelets in the body. This medicine is available only with your doctor's prescription.
Sep 1, 2024
People also ask
Oct 15, 2023 · Anagrelide is in a class of medications called platelet-reducing agents. It works by slowing the production of platelets in the body.
Anagrelide is a drug used for the treatment of essential thrombocytosis or overproduction of blood platelets. It also has been used in the treatment of ...
Anagrelide is indicated for the treatment of thrombocythemia, secondary to malignant neoplasms, to reduce platelet count and the associated risk of thrombosis.
Anagrelide hydrochloride is FDA approved for the treatment of patients with thrombocythemia, secondary to myeloproliferative disorders, to reduce the ...
Thrombocythemia. Indicated for essential thrombocythemia and for thrombocythemia secondary to myeloproliferative disorders to decrease risk thrombosis and ...
Anagrelide is used to treat a certain blood disorder (thrombocythemia), which is caused by your bone marrow making too many platelets.
Anagrelide is used to decrease the risk of blood clots in patients who have thrombocythemia (too many platelets in the blood). It works to decrease the ...
Jul 5, 2017 · Anagrelide is an antithrombotic and platelet reducing agent that is used to treat the thrombocythemia associated with myeloproliferative ...
Anagrelide inhibits cyclic. AMP phosphodiesterase III (PDEIII). PDEIII inhibitors can also inhibit platelet aggregation. However, significant inhibition of ...